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Abstract— For low-income countries, hypertension is the 
leading cause of death. Preeclampsia, a disorder often 
characterized by high blood pressure, is the second 
leading killer of pregnant women globally. Preeclampsia 
can be treated cheaply and effectively but very few 
women receive appropriate prenatal care.  There are 
many different devices to measure blood pressure but 
they are poorly suited for use in developing countries. 
Great care has to be taken to engineer a device that 
incorporates the human-factors involved while 
maintaining affordability. A prototype of a low-cost 
device engineered specifically for semi-literate volunteers 
in developing countries has been created.  Preliminary 
testing has shown reliable hypertension detection and 
plans have been made for field testing in rural 
communities this August 2010 in Nepal. 
I. INTRODUCTION 
ne of the biggest disputes in the government right now 
concerns the astronomical deficit generated primarily 
by health care.  The United States spent more than $2.3 
trillion on health care in 2008 according to the Kaiser Family 
Foundation, and it does not appear to be slowing down 
anytime soon [1]. In addition to tightening the reins on 
wasteful spending and changing health insurance policies,  it 
is necessary to find innovative new solutions to these very 
expensive problems.  Luckily, the investigation for low cost 
solutions can be greatly beneficial for people in developing 
nations who face similar problems with excessive spending.   
 




Global health care needs vary largely with the income 
level of the country so it is difficult to generalize what the 
biggest problems are worldwide. Consistently, countries with 
lower incomes have higher mortality rates; however the most 
fatal disorders differ with income level.  For developing 
countries, high blood pressure is the leading cause of death 
[2].  While it may be challenging to combat the causes of 
death directly, identifying the risks appropriately and dealing 
with those problems will have a large impact on preventable 
deaths.   
 
According to Gaziano et al, suboptimal blood pressure can 
have a severe economic impact.  Healthcare costs due to 
blood pressure problems have been estimated to be upwards 
of $370 billion or 10% of the world’s healthcare 
expenditures in 2001. Over a 10-year period, suboptimal 
blood pressure has been predicted to cost nearly $1 trillion 
globally with indirect costs reaching $3.6 trillion annually 
[3].  High blood pressure incurs costs far beyond that of the 
medication used to combat it.  Hypertension often leads to 
more complicated conditions such as heart disease which 
may demand expensive treatment or surgery. In developing 
countries, very few people are even screened for suboptimal 
blood pressure. This is due to the downfalls in the design of 
the devices currently available, and the amount of training 
that is often required to operate them.   
 
One example of a disorder that is receiving a lot of press 
and funding recently is preeclampsia.  Preeclampsia occurs 
during pregnancy and the postpartum period, and can have 
negative effects on both the mother and the unborn child.  It 
is the second largest killer of pregnant women; characterized 
by proteinuria (protein in the urine), and hypertension 
(systolic blood pressure greater than 140mmHg or diastolic 
blood pressure greater than 90mmHg). After onset, there is 
typically damage to the mother’s liver, kidneys, and 
endothelium in addition to vasoconstrictive factors being 
released which account for the increase in blood pressure.  
Preeclampsia refers to a set of symptoms rather than an 
underlying cause, which makes it relatively easy to screen for 
with the appropriate tools.  Preeclampsia is very treatable 
through the injection of magnesium sulfate, which is both 
cheap and effective. But this relies on an accurate and early 
recognition of the disorder [4].  Extremely few mothers die 
from preeclampsia in developed countries where prenatal 
care is very common. Unfortunately, very few women in 
developing countries receive the appropriate prenatal care 
required for diagnosis.  
























There are many devices to measure blood pressure with 
varying functions and price tags.  However, these are poorly 
suited for use in developing countries. Great care has to be 
taken to engineer a device that incorporates the human 
factors involved while maintaining affordability. Through 
collaboration with JHPIEGO, a non-profit affiliated with the 
Johns Hopkins University, certain needs have been isolated 
to ensure that the device will be readily accepted in the field.  
  
Aside from being able to detect hypertension, the device 
must be user-friendly.  According to the World Health 
Organization, over half of the births in Africa and Southeast 
Asia were not attended by skilled health personnel and over 
40% in the Eastern Mediterranean region were conducted 
without professional guidance [5]. This means that the 
device for detecting hypertension will be used by a semi-
literate community volunteer who may not be able to 
read/interpret systolic and diastolic measurements.  
Additionally, training and user-input should be minimized in 
order to limit possible errors.   JHPIEGO has requested the 
device be operable in one step and that the user should be 
able to go from training to competency in under one hour.   
 
It is important to note that the testing will be done during 
visits to the homes where pregnant women live. Women in 
deeply conservative societies will be unwilling to expose 
their upper arm to a volunteer to allow the application of a 
typical blood pressure cuff.  It has been recommended that a 
wrist cuff or finger-unit be incorporated with the design in 
order to limit these complications.  Additionally, most homes 
in isolated villages have very limited power supplies.  A 
system that requires a power outlet will never be adopted by 
the healthcare workers in the field.  The device must utilize 
batteries or an alternative source of power in order to 
maintain mobility.  
 
Finally, since the device is intended for developing 
countries such as Africa, Southern Asia, and the Middle 
East, certain design elements must be handled carefully.  
Figure 2 illustrates the countries of the world with territory 
sizes drawn proportionally to how much public spending 
goes towards healthcare.  While the spending on public 
health services per person (PPPUSS) for North America, 
Western Europe, and Japan is well over $1600, everywhere 
else it is less than $400 and often far less [6].  It is important 
to engineer the device cheaply and robustly so that countries 
can afford to buy these and be confident that they will 
survive extreme climates in addition to exposure to dirt, falls, 
and water.   
 
 
Figure 2 Countries of the world with territories drawn 
proportionally to spending on public health [6] 
 
B. Solution 
The Hypertension Detector for Developing Countries 
proposed in this paper has taken into account the above 
design criteria and is a working prototype appropriate for 
these unique needs.  All the design elements have been 
discussed and approved with JHPIEGO and optimized for 
use in developing countries by volunteers with minimal 
training. 
 
First, in order to reliably detect blood pressure, the 
oscillometric method has been utilized. According to 
Sapiński, et al. blood pressure can be determined by inflating 
the cuff to a high pressure and monitoring the pressure 
oscillations that occur with each heart beat as the cuff slowly 
deflates.   By keeping track of the pressure corresponding to 
the largest oscillation (representing the mean arterial 
pressure), the systolic blood pressure can be determined by 
checking what the pressure was directly before the 
oscillations increased above 40% of this height. Similarly, 
the diastolic blood pressure is computed by finding the 
pressure at which the oscillations have decreased to 60% of 
the max as shown in Figure  [7]. 
 
Figure 3 Standard algorithm for the oscillometric method of 
blood pressure measurement [7] 
 
 In addition to the implementation of this algorithm in the 
software of the microcontroller used in the device, there is 
signal processing of the pressure sensor output.  First there is 
DC filtering to bring the signal down to oscillations around 0 
volts.  Next there is amplification so that these oscillations 
are easily recognized by the analog to digital input ports of 
the microcontroller.  In conjunction with appropriate signal 
filtering, a very robust signal can be acquired.  A circuit 
  
diagram in addition to a flow chart summarizing the software 
algorithm can be found in the appendix.   
 
 Once blood pressure can be reliably calculated, human 
factors were taken into account.  Rather than spending 
money on an expensive LCD screen to portray exact 
numbers that may be difficult to interpret, the 
microcontroller will classify the blood pressure as 
hypertensive or healthy and display a binary red/green LED 
feedback.  To limit user error, the process has been reduced 
down to simply turning on the device, inflating the cuff until 
a yellow LED lights, and waiting as the cuff automatically 
deflates.  Once the microcontroller has calculated and 
interpreted the results, there will be LED feedback to let the 
user know if the mother is fine or needs to report to a 
hospital/local clinic for further testing and treatment.   
 
 Since the device is intended for use during a trip to a 
woman’s home by a volunteer, a wrist cuff has been utilized 
to comply with conservative cultures.  Moreover, wrist sizes 
will be more consistent from patient to patient compared to 
upper-arm sizes which are highly variable.  Since power can 
be hard to come by in developing countries, an alternative 
solution has been developed.   
 
Batteries are often expensive and have limited life.  The 
same is true even for rechargeable batteries which are 
typically even more expensive and harder to come by if a 
replacement is needed.  While enough energy can be 
harvested from the sun to power the system, solar cells are 
relatively expensive for their efficiency and are too fragile.  
Instead, a crank charger like those found in crank flashlights 
or radios has been incorporated in conjunction with a super-
capacitor.  The crank is more robust than solar panels and 
provides more than enough energy.  A partially-charged 
super-capacitor can be fully charged with merely twenty 
seconds of cranking.  Additionally, the super-capacitor has 
the advantage of being cheaper than batteries while 
supporting far more charge/discharge cycles.   The crank-
charging system will be able to provide power for the entire 
life of the device in even the most remote parts of the world.   
 
 
Figure 4 Examples of different power options suitable for 
developing countries: batteries, cranks, and solar panels 
III. RESULTS 
 
In order to illustrate the advantages of the new system, a 
thorough comparison must be made against what is currently 
on the market.   For a number of reasons, the new device 
satisfies developing countries’ needs in ways that intra-
arterial measurement, sphygmomanometers, assorted 
automatic blood pressure devices, and proteinuria 
measurement cannot. 
 
Intra-arterial measurement is the act of inserting a catheter 
equipped with a pressure sensor on the tip directly into the 
blood stream.  While this can be highly accurate, extensive 
training is required to operate the expensive recording 
equipment necessary [8].  Additionally, this is highly 
invasive and not appropriate for a volunteer visiting a 
patient’s home due to sterility and power needs.  
 
Sphygmomanometers are a very portable and low-cost 
method for measuring blood pressure.   They require no 
power but extensive training is necessary to be able to 
interpret the sounds heard through the stethoscope. As the 
cuff is gradually deflated by a manually controlled air valve, 
Korotkoff sounds appear and disappear at the systolic and 
diastolic pressure respectively [9].  Great care must be taken 
to deflate the cuff at the correct rate (2-3mmHg).  While 
these kits are relatively affordable, it is unreasonable to 
expect a large number of volunteers to become expertly 
trained in this skill.  
 
 
Figure 5 Measurement of blood pressure with a 
sphygmomanometer [9] 
 
There are a wide range of different automatic blood 
pressure systems currently on the market.  These operate in a 
similar fashion to the proposed device but lack key design 
elements that keep them from being accepted for wide use in 
developing countries.  Most devices are powered by batteries 
which have numerous drawbacks as detailed previously.  
They are also quite expensive with the cheapest costing $20 
and of poor quality, while units with more functionality can 
cost well over $100. There are numerous features such as 
  
memory, heart rate calculations, and irregular heartbeat 
detection that are confusing and increase the cost of the 
device.  In fact, very few devices have a hypertension 
detection feature which is the most important for our 
application. Some devices boast automatic inflation and 
deflation to minimize user input but these implementations 
are power-hungry and can easily be replaced with a manual 
inflation pump in conjunction with a leaky valve.   
 
 One example of a blood pressure device that has tried to 
focus on the needs of developing countries is the Microlife 
3AS1-2 [10].  The device is battery-powered (with a solar-
power charger being developed), but still displays the results 
on an LCD screen for interpretation. At $30, it is three times 
the desired cost put forward by JHPIEGO and would most 
likely fail to be accepted by the users it is targeting.  No 
thought has been put into engineering a device that is easy to 
use and interpret.  For example, it is unclear how much 
inflation is needed to ensure accurate results. Additionally, 
the current upper-arm cuff it utilizes would be difficult to 




Figure 6 The Microlife blood pressure device for use in low 
resource settings [10] 
 
 In addition to hypertension, preeclampsia may be 
diagnosed by the presence of proteinuria.  As an indication 
of early renal damage, a cheap way to determine the 
presence of dangerous levels of protein in the urine would 
work well in conjunction with a blood pressure device as a 
screening tool [11].  Machines costing upwards of $700 are 
available with reflectance photometers used to analyze the 
color and intensity of the light that reflectin off the reagent 
area of proteinuria strips.  The data from the machine must 
then be interpreted.  This requires training in addition to 
funds with which to purchase such a machine, along with 
electricity to power it.   
 
A more reasonable approach is the dipstick currently 
under development by JHPIEGO.  Proteins in solution will 
interfere with a dye-buffer combination causing a display 
panel to transform from yellow to green [12].  This color-
coding provides a way for volunteers to easily interpret 
results.  Additionally, this can be very portable as no power 
is needed.  Currently at $1 per use, the main drawback is the 
cost.  Since blood pressure devices can be reused on 
hundreds of patients, the cost per use is far less.  Until the 
price is further reduced, an affordable blood pressure device 




Figure 7 How different preeclampsia screening devices compare 
IV. DISCUSSION 
 
In conclusion, not one of the methods or devices currently 
available is appropriate for preeclampsia detection in 
developing countries.  A table comparing each device and 
how well it satisfies the needs of the project is shown in 
Figure 7.   
 
Our proposed device is capable of accurately detecting 
hypertension according to the oscillometric algorithm as 
used in most automatic blood pressure systems.  However, it 
is far more user-friendly due to the reduced number of steps 
required for use and the binary result feedback.  All the user 
must do is turn the crank until the green LED lights, pump 
until the yellow LED lights, and wait while the device 
automatically deflates and calculates the blood pressure. A 
red light indicates: go to a hospital/local clinic while green 
indicates: normal blood pressure. The wrist cuff included 
with the device accounts for conservative cultures while the 
crank eliminates any power supply issues.   
 
All of this for $15 manufacturing costs results in an 
elegant solution for an unmet global problem.  Moreover, the 
device is designed in a modular fashion.  Any available cuff, 
inflation bulb, or tubing, can be connected or disconnected 
via a universal port.  It is important to note that many 
countries support the use of crank powered flashlights and 
radios.  If the crank were to fail, it could easily be removed 
and replaced with only the attachment of two wires.  This 
can be completed by a local worker with basic electrical 
knowledge.  There is no need to completely replace the 
device or send it back to a developed country if certain parts 
  
fail.  As a first prototype, this device shows terrific potential 
to have an impact on the lives of many mothers and infants 
all over the world.   
 
 
Figure 8 A photograph of the new device.  Of note are the 
power crank and LED feedback 
 
Further work continues for the improvement of the device.  
It will soon require only a single step to use.  With the 
implementation of battery power in conjunction with a crank 
backup, the user would simply start pumping the inflation 
bulb which would wake up the device.  Next, an LED will 
alert the user when the cuff has been sufficiently inflated and 
the microcontroller will automatically determine the blood 
pressure, and give binary LED feedback as before.  Now that 
the device has been shown to work at low cost and low-
power, the focus has been shifted to human-factors.  In 
addition to ease of use, more care will be taken to improve 
the robustness of the device.  It will be water-proof in 
addition to shock-proof so that it can survive if a flood or 
drop occurs.   
 
 Great interest has been shown in the development of this 
device towards large-scale manufacturing.  JHPIEGO has 
estimated a need of nearly 10 million of these devices and 
field testing in rural communities has been planned for 
August 2010 in Nepal.   
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Figure 1 Circuit Diagram 
 
Figure 2 Algorithm Flow Chart 
